Basilea achieves preclinical milestone in oncology collaboration on potential first-in-class kinase inhibitor

NEXT STORY
Endoscopy Market revenue to cross USD 52 Bn by 2027: Global Market Insights, Inc.
PREV STORY
Predictive Oncology Announces $7.4 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Immuron Announces Board Appointment

MELBOURNE, Australia, June 25, 2018 (GLOBE NEWSWIRE) -- Australian biopharmaceutical company Immuron Limited (ASX:IMC), ...

author_avatar
NASDAQ Market News

OPKO Announces U.S. Launch of RAYALDEE™

MIAMI, Nov. 23, 2016 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq:OPK), today announced that ...

author_avatar
NASDAQ Market News

Director Declaration

18 August 2016 13:00 New external board appointment Listing Rule LR 9.6.14 R (2) ...

author_avatar
NASDAQ Market News